Search results
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 7 hours agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
Morningstar· 7 days agoData Highlight Positive Outcomes in Uncontrolled Gout With KRYSTEXXA® and Progress in Addressing Sjögren's Disease THOUSAND OAKS, Calif., June 12, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today ...
Identifying predictors for organ damage in children with systemic lupus erythematosus
Medical Xpress· 5 days agoAt their 2024 congress, EULAR—The European Alliance of Associations for Rheumatology—ran a session...
Real-World RA Data Find JAK Inhibitor Infection Risk Is Low
Medscape· 5 days agoIn patients with rheumatoid arthritis (RA), Janus kinase inhibitors (JAKi) are associated with a...
Data from multi-center study show several conditions are more common in people with osteoarthritis
Medical Xpress· 5 days agoOsteoarthritis is the most common arthritis worldwide, and has an increasing global burden of...
OA Patients Get Long-Term Benefit From Lifestyle Improvements
MedPage Today· 5 days ago...Osteoarthritis Index (WOMAC) total scores stood at about 15 points below the original baseline...
Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc
Medscape· 5 days agoThe researchers were led by Blaž Burja, MD, PhD, a physician-scientist at the Center of Experimental...
Predicting response in treatment-naïve RA: Harnessing the power of multi-modal analysis
Medical Xpress· 7 days agoNew work presented at the 2024 congress of EULAR—The European Alliance of Associations for ...
Exploring whether different joints have different treatment outcomes in cases of psoriatic arthritis
Medical Xpress· 7 days agoThere are many treatment options for psoriatic arthritis (PsA), and EULAR—The European Alliance of...
Low-dose glucocorticoids in systemic lupus erythematosus: New evidence around use and thresholds
Medical Xpress· 6 days agoHowever, data regarding the optimum dose target is conflicting. Recommendations from EULAR—The...